Wills Eye Hospital Ophthalmology Review Course 2026

Saturday, February 21, 2026, 6:30 AM - Wednesday, February 25, 2026, 5:00 PM, Wills Eye Auditorium, Philadelphia, PA

EARLY BIRD REGISTRATION OPEN NOW!

Early Bird pricing for the In-Person course is $850 per attendee through October 1, 2025.

Registration for the In-Person course is $950 per attendee after October 1, 2025.

Registration Fee includes

• High-quality lectures preparing attendees for exams

• 45.5 hours of course content

• Downloadable 1000+ page syllabus

• Breakfast, lunch, and refreshment breaks provided daily

• Access to faculty for questions

• One-year access to the OnDemand Review Course.

 

Registration Addons

• Printed binder of 1000+ page syllabus - $135

• Spiral bound copy of Dr. Guyton’s Optics & Refractions lecture (PDF version will be provided to all attendees for viewing) - $17.50

AMA PRA Category 1 Credits™ (45.50 hours), Non-Physician Attendance (45.50 hours)

Course Director: Ralph C. Eagle, Jr., MD

This live in-person course is a comprehensive and intensive review of ophthalmology for practicing ophthalmologists and ophthalmology residents and fellows. Topics taught by our world-renowned faculty range from anatomy, corneal diseases, eyelid, glaucoma, imaging, immunology, neuro-ophthalmology, oncology, orbit, ocular pathology, pediatrics, pharmacology, physiology, optics and refraction, and retina.

Guest Faculty
David L. Guyton, MD, Professor of Ophthalmology,
The Wilmer Ophthalmological Institute, Johns Hopkins University,
Baltimore, MD

Kristina Irsch, PhD, Assistant Professor of Ophthalmology,
The Wilmer Ophthalmological Institute, Johns Hopkins University,
Baltimore, MD

Rod Foroozan, MD, Professor of Neuro-ophthalmology,
Baylor College of Medicine,
Houston, TX

Hermann D. Schubert, MD, Professor of Clinical Ophthalmology and Pathology,
Columbia University,
New York, NY

Wills Eye Hospital Faculty 
Jurij R. Bilyk, MD, Attending Surgeon, Oculoplastic Service

Jacqueline Carrasco, MD, Attending Surgeon, Oculoplastic & Orbital Surgery

Ralph C. Eagle, Jr., MD, Service Chief, Department of Pathology

Mitchell S. Fineman, MD, Attending Surgeon, Retina Service

Jordan D. Deaner, MD, Attending Surgeon, Retina Service

Lauren Hock, MD, Attending Surgeon, Glaucoma Service

Aditya Kanesa-thasan, MD, Attending Surgeon, Cornea and Cataract Surgery

Michael A. Klufas, MD, Attending Surgeon, Retina Service

Daniel Lee, MD, Attending Surgeon, Glaucoma Service

Jonathan S. Myers, MD, Service Chief, Glaucoma Service

Bruce M. Schnall, MD, Attending Surgeon, Adult and Pediatric Strabismus

Carol L. Shields, MD, Service Chief, Oncology Service

Zeba A. Syed, MD, Attending Surgeon, Cornea Service

Barry N. Wasserman, MD, Attending Surgeon, Pediatric Ophthalmology Service

1. Provide a comprehensive review of topics in ophthalmology including: Optics and Refraction; Antomy and Embryology; Retina and Vitreous; Ocular Pathology; Orbit, Eyelid and Lacrimal System; Pharmacology and Therapeutics; Ocular Tumors; Neuro-Ophthalmology; Corneal and External Diseases; Uveitis and AIDS; Glaucoma; Pediatric Ophthalmology and Strabismus; CT and MRI Imaging of Eye and Orbit.
2. Better understand the pathophysiology of most ophthalmic disease.
3. Perform appropriate diagnostic tests and differential diagnosis for most ophthalmic diseases.

AMA PRA Statement
Wills Eye Hospital designates this for a maximum of 45.50 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Mitigation of Relevant Financial Relationships

In compliance with the Standards for Integrity and Independence in Accredited Continuing Education set by the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of Wills Eye Hospital that the information presented at CME activities will be commercially unbiased and based upon clinical and scientific evidence. To help participants make judgments about the presence of commercial bias, Wills Eye Hospital provides information that all individuals in a position to control the content of a CME activity (including faculty, planners, reviewers or others) have disclosed about all financial relationships they have with ineligible companies. All relevant financial relationships have been mitigated.

Ineligible companies are companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if the educational content an individual can control is related to the business lines or products of the ineligible company. The CME activity staff at Wills Eye Hospital report no financial relationships with ineligible companies.